{"id":"https://openalex.org/W3178697376","doi":"https://doi.org/10.2147/dddt.s308610","title":"A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TPN171H, a Novel Phosphodiesterase Type 5 Inhibitor, in Healthy Subjects","display_name":"A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TPN171H, a Novel Phosphodiesterase Type 5 Inhibitor, in Healthy Subjects","publication_year":2021,"publication_date":"2021-07-01","ids":{"openalex":"https://openalex.org/W3178697376","doi":"https://doi.org/10.2147/dddt.s308610","mag":"3178697376","pmid":"https://pubmed.ncbi.nlm.nih.gov/34262260","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8273902"},"language":"en","primary_location":{"id":"doi:10.2147/dddt.s308610","doi":"https://doi.org/10.2147/dddt.s308610","is_oa":true,"landing_page_url":"https://doi.org/10.2147/dddt.s308610","pdf_url":"https://www.dovepress.com/getfile.php?fileID=71340","source":{"id":"https://openalex.org/S2496126384","display_name":"Drug Design Development and Therapy","issn_l":"1177-8881","issn":["1177-8881"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Design, Development and Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.dovepress.com/getfile.php?fileID=71340","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101079960","display_name":"Hongjie Qian","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117527","display_name":"Shanghai Xuhui Central Hospital","ror":"https://ror.org/01whmzn59","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210117527"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Hongjie Qian","raw_affiliation_strings":["Central Laboratory, Shanghai Xuhui Central Hospital, Shanghai, 200031, People's Republic of China","Shanghai Engineering Research Center of Phase I Clinical Research & Quality Consistency Evaluation for Drugs, Shanghai, 200031, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Central Laboratory, Shanghai Xuhui Central Hospital, Shanghai, 200031, People's Republic of China","institution_ids":["https://openalex.org/I4210117527"]},{"raw_affiliation_string":"Shanghai Engineering Research Center of Phase I Clinical Research & Quality Consistency Evaluation for Drugs, Shanghai, 200031, People's Republic of China","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Qian Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117527","display_name":"Shanghai Xuhui Central Hospital","ror":"https://ror.org/01whmzn59","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210117527"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Qian Chen","raw_affiliation_strings":["Central Laboratory, Shanghai Xuhui Central Hospital, Shanghai, 200031, People's Republic of China","Shanghai Engineering Research Center of Phase I Clinical Research & Quality Consistency Evaluation for Drugs, Shanghai, 200031, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Central Laboratory, Shanghai Xuhui Central Hospital, Shanghai, 200031, People's Republic of China","institution_ids":["https://openalex.org/I4210117527"]},{"raw_affiliation_string":"Shanghai Engineering Research Center of Phase I Clinical Research & Quality Consistency Evaluation for Drugs, Shanghai, 200031, People's Republic of China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060575663","display_name":"Liyu Liang","orcid":"https://orcid.org/0000-0002-0175-3368","observed_orcids":["https://orcid.org/0000-0002-0175-3368"]},"institutions":[{"id":"https://openalex.org/I4210117527","display_name":"Shanghai Xuhui Central Hospital","ror":"https://ror.org/01whmzn59","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210117527"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Liyu Liang","raw_affiliation_strings":["Central Laboratory, Shanghai Xuhui Central Hospital, Shanghai, 200031, People's Republic of China","Shanghai Engineering Research Center of Phase I Clinical Research & Quality Consistency Evaluation for Drugs, Shanghai, 200031, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Central Laboratory, Shanghai Xuhui Central Hospital, Shanghai, 200031, People's Republic of China","institution_ids":["https://openalex.org/I4210117527"]},{"raw_affiliation_string":"Shanghai Engineering Research Center of Phase I Clinical Research & Quality Consistency Evaluation for Drugs, Shanghai, 200031, People's Republic of China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102778331","display_name":"Yang Zou","orcid":"https://orcid.org/0000-0003-0887-7096","observed_orcids":["https://orcid.org/0000-0003-0887-7096"]},"institutions":[{"id":"https://openalex.org/I4210117527","display_name":"Shanghai Xuhui Central Hospital","ror":"https://ror.org/01whmzn59","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210117527"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yang Zou","raw_affiliation_strings":["Central Laboratory, Shanghai Xuhui Central Hospital, Shanghai, 200031, People's Republic of China","Shanghai Engineering Research Center of Phase I Clinical Research & Quality Consistency Evaluation for Drugs, Shanghai, 200031, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Central Laboratory, Shanghai Xuhui Central Hospital, Shanghai, 200031, People's Republic of China","institution_ids":["https://openalex.org/I4210117527"]},{"raw_affiliation_string":"Shanghai Engineering Research Center of Phase I Clinical Research & Quality Consistency Evaluation for Drugs, Shanghai, 200031, People's Republic of China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112661183","display_name":"Huahua Pu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117527","display_name":"Shanghai Xuhui Central Hospital","ror":"https://ror.org/01whmzn59","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210117527"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Huahua Pu","raw_affiliation_strings":["Central Laboratory, Shanghai Xuhui Central Hospital, Shanghai, 200031, People's Republic of China","Shanghai Engineering Research Center of Phase I Clinical Research & Quality Consistency Evaluation for Drugs, Shanghai, 200031, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Central Laboratory, Shanghai Xuhui Central Hospital, Shanghai, 200031, People's Republic of China","institution_ids":["https://openalex.org/I4210117527"]},{"raw_affiliation_string":"Shanghai Engineering Research Center of Phase I Clinical Research & Quality Consistency Evaluation for Drugs, Shanghai, 200031, People's Republic of China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110443425","display_name":"Liang Xin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117527","display_name":"Shanghai Xuhui Central Hospital","ror":"https://ror.org/01whmzn59","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210117527"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Liang Xin","raw_affiliation_strings":["Central Laboratory, Shanghai Xuhui Central Hospital, Shanghai, 200031, People's Republic of China","Shanghai Engineering Research Center of Phase I Clinical Research & Quality Consistency Evaluation for Drugs, Shanghai, 200031, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Central Laboratory, Shanghai Xuhui Central Hospital, Shanghai, 200031, People's Republic of China","institution_ids":["https://openalex.org/I4210117527"]},{"raw_affiliation_string":"Shanghai Engineering Research Center of Phase I Clinical Research & Quality Consistency Evaluation for Drugs, Shanghai, 200031, People's Republic of China","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Rong Song","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117527","display_name":"Shanghai Xuhui Central Hospital","ror":"https://ror.org/01whmzn59","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210117527"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Rong Song","raw_affiliation_strings":["Central Laboratory, Shanghai Xuhui Central Hospital, Shanghai, 200031, People's Republic of China","Shanghai Engineering Research Center of Phase I Clinical Research & Quality Consistency Evaluation for Drugs, Shanghai, 200031, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Central Laboratory, Shanghai Xuhui Central Hospital, Shanghai, 200031, People's Republic of China","institution_ids":["https://openalex.org/I4210117527"]},{"raw_affiliation_string":"Shanghai Engineering Research Center of Phase I Clinical Research & Quality Consistency Evaluation for Drugs, Shanghai, 200031, People's Republic of China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100416475","display_name":"Tingting Li","orcid":"https://orcid.org/0000-0002-6113-1624","observed_orcids":["https://orcid.org/0000-0002-6113-1624","https://orcid.org/0009-0006-2836-2064"]},"institutions":[{"id":"https://openalex.org/I4210117527","display_name":"Shanghai Xuhui Central Hospital","ror":"https://ror.org/01whmzn59","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210117527"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Tingting Li","raw_affiliation_strings":["Central Laboratory, Shanghai Xuhui Central Hospital, Shanghai, 200031, People's Republic of China","Shanghai Engineering Research Center of Phase I Clinical Research & Quality Consistency Evaluation for Drugs, Shanghai, 200031, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Central Laboratory, Shanghai Xuhui Central Hospital, Shanghai, 200031, People's Republic of China","institution_ids":["https://openalex.org/I4210117527"]},{"raw_affiliation_string":"Shanghai Engineering Research Center of Phase I Clinical Research & Quality Consistency Evaluation for Drugs, Shanghai, 200031, People's Republic of China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100554265","display_name":"Huijuan Zhu","orcid":"https://orcid.org/0000-0003-2751-2607","observed_orcids":["https://orcid.org/0000-0003-2751-2607"]},"institutions":[{"id":"https://openalex.org/I4210117527","display_name":"Shanghai Xuhui Central Hospital","ror":"https://ror.org/01whmzn59","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210117527"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Huijuan Zhu","raw_affiliation_strings":["Central Laboratory, Shanghai Xuhui Central Hospital, Shanghai, 200031, People's Republic of China","Shanghai Engineering Research Center of Phase I Clinical Research & Quality Consistency Evaluation for Drugs, Shanghai, 200031, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Central Laboratory, Shanghai Xuhui Central Hospital, Shanghai, 200031, People's Republic of China","institution_ids":["https://openalex.org/I4210117527"]},{"raw_affiliation_string":"Shanghai Engineering Research Center of Phase I Clinical Research & Quality Consistency Evaluation for Drugs, Shanghai, 200031, People's Republic of China","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Yu Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I19820366","display_name":"Chinese Academy of Sciences","ror":"https://ror.org/034t30j35","country_code":"CN","type":"government","lineage":["https://openalex.org/I19820366"]},{"id":"https://openalex.org/I4210112820","display_name":"Shanghai Institute of Materia Medica","ror":"https://ror.org/022syn853","country_code":"CN","type":"facility","lineage":["https://openalex.org/I19820366","https://openalex.org/I4210112820"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yu Wang","raw_affiliation_strings":["CAS Key Laboratory of Receptor Research, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CAS Key Laboratory of Receptor Research, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, People's Republic of China","institution_ids":["https://openalex.org/I19820366","https://openalex.org/I4210112820"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007878143","display_name":"Guanghui Tian","orcid":"https://orcid.org/0000-0002-7988-5715","observed_orcids":["https://orcid.org/0000-0002-7988-5715"]},"institutions":[{"id":"https://openalex.org/I4405267959","display_name":"Vigonvita Life Sciences Co., Ltd. (China)","ror":"https://ror.org/055wcyn58","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405267959"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Guanghui Tian","raw_affiliation_strings":["Vigonvita Life Science Co., Ltd., Suzhou, 215123, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vigonvita Life Science Co., Ltd., Suzhou, 215123, People's Republic of China","institution_ids":["https://openalex.org/I4405267959"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008792226","display_name":"Jingshan Shen","orcid":"https://orcid.org/0000-0001-9679-9934","observed_orcids":["https://orcid.org/0000-0001-9679-9934"]},"institutions":[{"id":"https://openalex.org/I19820366","display_name":"Chinese Academy of Sciences","ror":"https://ror.org/034t30j35","country_code":"CN","type":"government","lineage":["https://openalex.org/I19820366"]},{"id":"https://openalex.org/I4210112820","display_name":"Shanghai Institute of Materia Medica","ror":"https://ror.org/022syn853","country_code":"CN","type":"facility","lineage":["https://openalex.org/I19820366","https://openalex.org/I4210112820"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jingshan Shen","raw_affiliation_strings":["CAS Key Laboratory of Receptor Research, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, People's Republic of China","Shanghai Engineering Research Center of Phase I Clinical Research & Quality Consistency Evaluation for Drugs, Shanghai, 200031, People's Republic of China"],"raw_orcid":"https://orcid.org/0000-0001-9679-9934","affiliations":[{"raw_affiliation_string":"CAS Key Laboratory of Receptor Research, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, People's Republic of China","institution_ids":["https://openalex.org/I19820366","https://openalex.org/I4210112820"]},{"raw_affiliation_string":"Shanghai Engineering Research Center of Phase I Clinical Research & Quality Consistency Evaluation for Drugs, Shanghai, 200031, People's Republic of China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001392142","display_name":"Hualiang Jiang","orcid":"https://orcid.org/0000-0003-0656-6315","observed_orcids":["https://orcid.org/0000-0003-0656-6315"]},"institutions":[{"id":"https://openalex.org/I19820366","display_name":"Chinese Academy of Sciences","ror":"https://ror.org/034t30j35","country_code":"CN","type":"government","lineage":["https://openalex.org/I19820366"]},{"id":"https://openalex.org/I4210112820","display_name":"Shanghai Institute of Materia Medica","ror":"https://ror.org/022syn853","country_code":"CN","type":"facility","lineage":["https://openalex.org/I19820366","https://openalex.org/I4210112820"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Hualiang Jiang","raw_affiliation_strings":["CAS Key Laboratory of Receptor Research, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, People's Republic of China","Shanghai Engineering Research Center of Phase I Clinical Research & Quality Consistency Evaluation for Drugs, Shanghai, 200031, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CAS Key Laboratory of Receptor Research, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, People's Republic of China","institution_ids":["https://openalex.org/I19820366","https://openalex.org/I4210112820"]},{"raw_affiliation_string":"Shanghai Engineering Research Center of Phase I Clinical Research & Quality Consistency Evaluation for Drugs, Shanghai, 200031, People's Republic of China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105413731","display_name":"Chen Yu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117527","display_name":"Shanghai Xuhui Central Hospital","ror":"https://ror.org/01whmzn59","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210117527"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Chen Yu","raw_affiliation_strings":["Central Laboratory, Shanghai Xuhui Central Hospital, Shanghai, 200031, People's Republic of China","Shanghai Engineering Research Center of Phase I Clinical Research & Quality Consistency Evaluation for Drugs, Shanghai, 200031, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Central Laboratory, Shanghai Xuhui Central Hospital, Shanghai, 200031, People's Republic of China","institution_ids":["https://openalex.org/I4210117527"]},{"raw_affiliation_string":"Shanghai Engineering Research Center of Phase I Clinical Research & Quality Consistency Evaluation for Drugs, Shanghai, 200031, People's Republic of China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100422287","display_name":"Zhen Wang","orcid":"https://orcid.org/0000-0001-9450-2260","observed_orcids":["https://orcid.org/0000-0001-9450-2260"]},"institutions":[{"id":"https://openalex.org/I19820366","display_name":"Chinese Academy of Sciences","ror":"https://ror.org/034t30j35","country_code":"CN","type":"government","lineage":["https://openalex.org/I19820366"]},{"id":"https://openalex.org/I4210112820","display_name":"Shanghai Institute of Materia Medica","ror":"https://ror.org/022syn853","country_code":"CN","type":"facility","lineage":["https://openalex.org/I19820366","https://openalex.org/I4210112820"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Zhen Wang","raw_affiliation_strings":["CAS Key Laboratory of Receptor Research, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, People's Republic of China","Shanghai Engineering Research Center of Phase I Clinical Research & Quality Consistency Evaluation for Drugs, Shanghai, 200031, People's Republic of China"],"raw_orcid":"https://orcid.org/0000-0001-9450-2260","affiliations":[{"raw_affiliation_string":"CAS Key Laboratory of Receptor Research, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, People's Republic of China","institution_ids":["https://openalex.org/I19820366","https://openalex.org/I4210112820"]},{"raw_affiliation_string":"Shanghai Engineering Research Center of Phase I Clinical Research & Quality Consistency Evaluation for Drugs, Shanghai, 200031, People's Republic of China","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5038725556","display_name":"Jingying Jia","orcid":"https://orcid.org/0000-0002-2492-3219","observed_orcids":["https://orcid.org/0000-0002-2492-3219"]},"institutions":[{"id":"https://openalex.org/I4210117527","display_name":"Shanghai Xuhui Central Hospital","ror":"https://ror.org/01whmzn59","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210117527"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Jingying Jia","raw_affiliation_strings":["Central Laboratory, Shanghai Xuhui Central Hospital, Shanghai, 200031, People's Republic of China","Shanghai Engineering Research Center of Phase I Clinical Research & Quality Consistency Evaluation for Drugs, Shanghai, 200031, People's Republic of China"],"raw_orcid":"https://orcid.org/0000-0002-2492-3219","affiliations":[{"raw_affiliation_string":"Central Laboratory, Shanghai Xuhui Central Hospital, Shanghai, 200031, People's Republic of China","institution_ids":["https://openalex.org/I4210117527"]},{"raw_affiliation_string":"Shanghai Engineering Research Center of Phase I Clinical Research & Quality Consistency Evaluation for Drugs, Shanghai, 200031, People's Republic of China","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5038725556"],"corresponding_institution_ids":["https://openalex.org/I4210117527"],"apc_list":{"value":2836,"currency":"USD","value_usd":2836},"apc_paid":{"value":2836,"currency":"USD","value_usd":2836},"fwci":0.4753,"has_fulltext":true,"cited_by_count":14,"citation_normalized_percentile":{"value":0.62498319,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"Volume 15","issue":null,"first_page":"2947","last_page":"2959"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10728","display_name":"Pulmonary Hypertension Research and Treatments","score":0.7910000085830688,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10728","display_name":"Pulmonary Hypertension Research and Treatments","score":0.7910000085830688,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12434","display_name":"Phosphodiesterase function and regulation","score":0.10530000180006027,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.03880000114440918,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/phosphodiesterase-5-inhibitors","display_name":"phosphodiesterase-5 inhibitors","score":0.9860000014305115},{"id":"https://openalex.org/keywords/pulmonary-arterial-hypertension","display_name":"pulmonary arterial hypertension","score":0.9959999918937683},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9729999899864197},{"id":"https://openalex.org/keywords/food-effect","display_name":"food effect","score":0.7879999876022339},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.8539999723434448},{"id":"https://openalex.org/keywords/single-ascending-dose","display_name":"single ascending dose","score":0.6859999895095825},{"id":"https://openalex.org/keywords/multiple-ascending-dose","display_name":"multiple ascending dose","score":0.984000027179718},{"id":"https://openalex.org/keywords/accumulation","display_name":"accumulation","score":0.33000001311302185},{"id":"https://openalex.org/keywords/healthy-volunteers","display_name":"healthy volunteers","score":0.6539999842643738}],"concepts":[{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.9088660478591919},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8994501829147339},{"id":"https://openalex.org/C22979827","wikidata":"https://www.wikidata.org/wiki/Q5137311","display_name":"Cmax","level":3,"score":0.8601875901222229},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.6787390112876892},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6649162769317627},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6080144047737122},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5978564620018005},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5228895545005798},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.41732946038246155},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32061833143234253},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011744","descriptor_name":"Pyrimidinones","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011744","descriptor_name":"Pyrimidinones","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011744","descriptor_name":"Pyrimidinones","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018565","descriptor_name":"Food-Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058986","descriptor_name":"Phosphodiesterase 5 Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D058986","descriptor_name":"Phosphodiesterase 5 Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D058986","descriptor_name":"Phosphodiesterase 5 Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.2147/dddt.s308610","doi":"https://doi.org/10.2147/dddt.s308610","is_oa":true,"landing_page_url":"https://doi.org/10.2147/dddt.s308610","pdf_url":"https://www.dovepress.com/getfile.php?fileID=71340","source":{"id":"https://openalex.org/S2496126384","display_name":"Drug Design Development and Therapy","issn_l":"1177-8881","issn":["1177-8881"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Design, Development and Therapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8273902","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8273902","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Des Devel Ther","raw_type":"Text"},{"id":"pmid:34262260","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34262260","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug design, development and therapy","raw_type":"Clinical Trial, Phase I"},{"id":"pmh:oai:doaj.org/article:9e6625fc650f4fc5a67e6b10d73cdef8","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/9e6625fc650f4fc5a67e6b10d73cdef8","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Drug Design, Development and Therapy, Vol Volume 15, Pp 2947-2959 (2021)","raw_type":"article"},{"id":"pmh:oai:dovepress.com/66624","doi":null,"is_oa":true,"landing_page_url":"https://www.dovepress.com/a-phase-i-study-to-evaluate-the-safety-tolerability-and-pharmacokineti-peer-reviewed-fulltext-article-DDDT","pdf_url":null,"source":{"id":"https://openalex.org/S4306401012","display_name":"Dove Medical Press (Taylor and Francis Group)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.2147/dddt.s308610","doi":"https://doi.org/10.2147/dddt.s308610","is_oa":true,"landing_page_url":"https://doi.org/10.2147/dddt.s308610","pdf_url":"https://www.dovepress.com/getfile.php?fileID=71340","source":{"id":"https://openalex.org/S2496126384","display_name":"Drug Design Development and Therapy","issn_l":"1177-8881","issn":["1177-8881"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Design, Development and Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G4363245776","display_name":null,"funder_award_id":"2018ZX09711002","funder_id":"https://openalex.org/F4320336020","funder_display_name":"National Key New Drug Creation and Manufacturing Program, Ministry of Science and Technology"},{"id":"https://openalex.org/G6006754559","display_name":null,"funder_award_id":"XDA12040103","funder_id":"https://openalex.org/F4320321133","funder_display_name":"Chinese Academy of Sciences"}],"funders":[{"id":"https://openalex.org/F4320321133","display_name":"Chinese Academy of Sciences","ror":"https://ror.org/034t30j35"},{"id":"https://openalex.org/F4320336020","display_name":"National Key New Drug Creation and Manufacturing Program, Ministry of Science and Technology","ror":null}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3178697376.pdf","grobid_xml":"https://content.openalex.org/works/W3178697376.grobid-xml"},"referenced_works_count":18,"referenced_works":["https://openalex.org/W1558292706","https://openalex.org/W1567859570","https://openalex.org/W1960650662","https://openalex.org/W2004405846","https://openalex.org/W2011477996","https://openalex.org/W2037180336","https://openalex.org/W2121376498","https://openalex.org/W2148038451","https://openalex.org/W2148797779","https://openalex.org/W2158862125","https://openalex.org/W2159885935","https://openalex.org/W2166964193","https://openalex.org/W2313326603","https://openalex.org/W2342923657","https://openalex.org/W2905582258","https://openalex.org/W2942145199","https://openalex.org/W3088705025","https://openalex.org/W3113102400"],"related_works":["https://openalex.org/W4409805144","https://openalex.org/W4282922254","https://openalex.org/W4409649265","https://openalex.org/W4402215652","https://openalex.org/W2942145199","https://openalex.org/W4412363282","https://openalex.org/W7160529674","https://openalex.org/W3134567410","https://openalex.org/W7169723661","https://openalex.org/W7162054944"],"abstract_inverted_index":{"Purpose:":[0],"TPN171H":[1,35,93,146,158,193,206,213,227,254],"is":[2],"a":[3,195,249],"novel,":[4],"potent":[5],"and":[6,32,41,53,76,120,128,188,223,230,242,262],"selective":[7],"phosphodiesterase":[8],"type":[9],"5":[10],"(PDE5)":[11],"inhibitor":[12],"for":[13,111,186],"the":[14,29,48,91,107,137,181,238],"treatment":[15],"of":[16,23,34,55,63,84,145,245,253],"pulmonary":[17],"arterial":[18],"hypertension":[19],"(PAH).":[20],"The":[21,58],"objective":[22],"this":[24],"study":[25,60],"was":[26,61,97,115,147,214,228],"to":[27,46,133,216],"evaluate":[28],"safety,":[30,270],"tolerability,":[31],"pharmacokinetics":[33,52],"in":[36,44,90,233,255,259],"healthy":[37,86,234,260,274],"subjects":[38,87,261,275],"after":[39,205],"single":[40],"multiple":[42],"dosing,":[43],"addition,":[45],"investigate":[47],"food":[49,240,272],"effect":[50,74,175],"on":[51,176,220,237],"safety":[54,243],"TPN171H.":[56],"Methods:":[57],"entire":[59],"comprised":[62],"three":[64],"parts:":[65],"Part":[66,71,77,125,152,179],"I":[67],"(single":[68],"ascending-dose":[69,80],"study),":[70,75],"II":[72],"(food":[73],"III":[78],"(multiple":[79],"study).":[81],"A":[82],"total":[83],"63":[85],"were":[88,104,131,202],"enrolled":[89],"study.":[92],"tablet":[94],"or":[95],"placebo":[96],"administered":[98],"per":[99],"protocol":[100],"requirements.":[101],"Blood":[102],"samples":[103],"collected":[105],"at":[106,184],"designated":[108],"time":[109],"points":[110],"pharmacokinetic":[112],"analysis.":[113],"Safety":[114],"assessed":[116],"by":[117],"clinical":[118,257],"examinations":[119],"adverse":[121],"events.":[122],"Results:":[123],"In":[124,151,178],"I,":[126],"AUC":[127,187],"C":[129,165,189],"max":[130,166,170,190],"proved":[132],"be":[134],"linear":[135],"within":[136],"5\u2013":[138],"30":[139],"mg":[140],"dose":[141],"range.":[142],"T":[143,169],"1/2":[144],"8.02\u2013":[148],"10.88":[149],"h.":[150],"II,":[153],"we":[154,247],"figured":[155],"out":[156],"that":[157,192],"administration":[159,252],"under":[160],"fed":[161],"condition":[162],"could":[163],"decrease":[164],",":[167,171],"prolong":[168],"but":[172],"had":[173],"no":[174,218],"AUC.":[177],"III,":[180],"accumulation":[182,197],"ratio":[183],"steady-state":[185],"indicated":[191],"has":[194],"slight":[196],"upon":[198],"repeated":[199],"dosing.":[200],"Subjects":[201],"generally":[203,231],"tolerable":[204],"administration.":[207],"Compared":[208],"with":[209,264],"other":[210],"PDE5":[211,268],"inhibitors,":[212],"found":[215],"have":[217],"impact":[219],"blood":[221],"pressure":[222],"color":[224],"discrimination.":[225],"Conclusion:":[226],"safe":[229],"tolerated":[232],"subjects.":[235],"Based":[236],"half-life,":[239],"effect,":[241,273],"profile":[244],"TPN171H,":[246,267],"recommend":[248],"once-daily,":[250],"post-meal":[251],"subsequent":[256],"studies":[258],"patients":[263],"PAH.":[265],"Keywords:":[266],"inhibitor,":[269],"pharmacokinetics,":[271]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2021-07-19T00:00:00"}